Treatment of Parkinson's disease in early and late phases. Use of pharmacological agents with special reference to deprenyl (selegiline)

MELVIN D. YAHR, MARINA R. MENDOZA, DANIEL MOROS, KENNETH J. BERGMANN

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'Treatment of Parkinson's disease in early and late phases. Use of pharmacological agents with special reference to deprenyl (selegiline)'. Together they form a unique fingerprint.

Medicine & Life Sciences